ARCA BIOPHARMA INC (ABIO) Stock Price, Quote, News and Overview
NASDAQ:ABIO - Nasdaq - US00211Y5069 - Common Stock - Currency: USD
ABIO Quote, Performance and Key Statistics
2.4
-0.1 (-4%)
The current stock price of ABIO is 2.4 USD. In the past month the price decreased by -22.83%. In the past year, price increased by 16.57%.
ABIO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.12 | 329.14B | ||
| AMGN | AMGEN INC | 14.17 | 150.99B | ||
| GILD | GILEAD SCIENCES INC | 13.33 | 128.61B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1702.9 | 126.96B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.2 | 65.88B | ||
| ARGX | ARGENX SE - ADR | 323.56 | 37.54B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.72B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.39B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.52B | ||
| NTRA | NATERA INC | N/A | 20.79B | ||
| BIIB | BIOGEN INC | 7.22 | 17.39B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.30B |
Related stock screener links
About ABIO
Company Profile
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The company is headquartered in Westminster, Colorado and currently employs 4 full-time employees. The company went IPO on 2000-07-21. The firm's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. Gencaro is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties that is developing for the treatment of atrial fibrillation in patients with heart failure. Its Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), is a protein therapeutic in clinical development as a potential treatment for patients with COVID-19. The company is also evaluating options for development of its assets, including partnering and other strategic options.
Company Info
ARCA BIOPHARMA INC
10170 Church Ranch Way, Suite 100
Westminster COLORADO 80021 US
CEO: Michael R. Bristow
Employees: 4
Company Website: https://arcabio.com/
Phone: 17209402200
ARCA BIOPHARMA INC / ABIO FAQ
What is the stock price of ARCA BIOPHARMA INC today?
The current stock price of ABIO is 2.4 USD. The price decreased by -4% in the last trading session.
What is the ticker symbol for ARCA BIOPHARMA INC stock?
The exchange symbol of ARCA BIOPHARMA INC is ABIO and it is listed on the Nasdaq exchange.
On which exchange is ABIO stock listed?
ABIO stock is listed on the Nasdaq exchange.
What is ARCA BIOPHARMA INC worth?
ARCA BIOPHARMA INC (ABIO) has a market capitalization of 34.82M USD. This makes ABIO a Nano Cap stock.
How many employees does ARCA BIOPHARMA INC have?
ARCA BIOPHARMA INC (ABIO) currently has 4 employees.
Should I buy ARCA BIOPHARMA INC (ABIO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ABIO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ABIO, evaluating the profitability, health, valuation and growth aspects
- ARCA BIOPHARMA INC (ABIO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ARCA BIOPHARMA INC (ABIO) Sales and EPS estimates to see what analysts future expectations are.
- ARCA BIOPHARMA INC (ABIO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ARCA BIOPHARMA INC (ABIO) Insider and Institutional Ownership to learn about the owners and their transactions.
- ARCA BIOPHARMA INC (ABIO) Stock Chart to make your own analysis
- ARCA BIOPHARMA INC (ABIO) Latest news and press-releases to stay up to date.
Does ARCA BIOPHARMA INC (ABIO) stock pay dividends?
ARCA BIOPHARMA INC (ABIO) has a dividend yield of 67.21%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of ABIO dividend history, reliability and sustainability.
When does ARCA BIOPHARMA INC (ABIO) report earnings?
ARCA BIOPHARMA INC (ABIO) will report earnings on 2024-10-16, after the market close.
What is the Price/Earnings (PE) ratio of ARCA BIOPHARMA INC (ABIO)?
ARCA BIOPHARMA INC (ABIO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.5).
ABIO Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ABIO. When comparing the yearly performance of all stocks, ABIO is a bad performer in the overall market: 75.71% of all stocks are doing better.
ABIO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ABIO. No worries on liquidiy or solvency for ABIO as it has an excellent financial health rating, but there are worries on the profitability.
ABIO Financial Highlights
Over the last trailing twelve months ABIO reported a non-GAAP Earnings per Share(EPS) of -0.5. The EPS decreased by -13.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.27% | ||
| ROE | -22.1% | ||
| Debt/Equity | 0 |
ABIO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ABIO. The Buy consensus is the average rating of analysts ratings from 7 analysts.